Monika Joshi, Stephanie C. Pero, Yves Durocher, Yujing Sun, Girja Shukla, Colleen Murphy, Ramiro Barrantes-Reynolds, Catherine Bernard, Gary Welch, David N. Krag. "Phase 1, open-label clinical trial to treat stage IV cancer patients harboring multiple patient-specific mutated cell surface proteins with chimeric antibodies.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps2672